Compare Amgen, Inc. (AMGN) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Modine Manufacturing Company — how do they compare? Amgen, Inc. trades at $415.54 (market cap $224.14B), while Modine Manufacturing Company trades at $203.09 (market cap $10.53B). The key difference: Amgen, Inc. is far larger — about 21.3× Modine Manufacturing Company's market cap, and Amgen, Inc. pays a 2.43% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.
| AMGN | MOD | |
|---|---|---|
Market Cap | $224.14B | $10.53B |
Sector | Health | Technology |
52-Week High | $417.20 | $306.89 |
52-Week Low | $271.18 | $119.68 |
Enterprise Value | $267.45B | $10.97B |
Dividend Yield | 2.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Amgen (AMGN) trades at $416.74, showing minimal daily movement with a slight 0.11% decline. The stock maintains strong technical momentum with bullish moving averages and support at $412. Fundamentally, the company demonstrates robust performance with Q2 2026 EPS beating estimates at $6.29 versus $5.62 expected, while revenue growth continues with 2025 revenue reaching $36.75 billion. Analyst sentiment remains positive with 59% buy ratings, though the current price exceeds the consensus target of $394.69.
Amgen presents a mixed outlook with strong earnings momentum and product growth offset by valuation concerns. Investment opportunities include continued blockbuster drug performance and raised 2026 guidance, while risks involve high debt levels and potential data breach litigation impacts. The stock's current premium valuation requires sustained execution to justify further upside.
Modine Manufacturing (MOD) trades at $206.94, up 8.34% with strong recent earnings beats but faces technical bearish signals. The company shows robust revenue growth driven by data center demand, though margins are under pressure. Analyst consensus remains strongly bullish with a $319 price target, while institutional activity shows mixed positioning amid valuation concerns.
MOD presents growth potential from data center expansion but carries valuation and execution risks. The stock's high P/E of 74 and margin compression create headwinds, while technical indicators suggest near-term weakness. Investors should weigh strong analyst support against stretched valuations and competitive pressures in thermal management markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
